News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

KineMed, Inc. and CHDI Foundation Announce Study to Investigate Role of Brain Cholesterol Synthesis and Lipid Metabolism in Huntington’s Disease


6/13/2012 10:08:16 AM

EMERYVILLE, Calif. & NEW YORK--(BUSINESS WIRE)--KineMed Inc. (www.kinemed.com) and CHDI Foundation, Inc. announced today a collaboration to investigate the role of the metabolism of cholesterol and other lipids in Huntington’s disease (HD). Research leading up to this study suggests that the homeostatic processes that control the balance of cholesterol in the brain are altered in HD patients.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES